References
- MenonGKNew insights into skin structure: scratching the surfaceAdv Drug Deliv Rev200254Suppl 1S3S1712460712
- MoserKKriwetKNaikAKaliaYNGuyRHPassive skin penetration enhancement and its quantification in vitroEur J Pharm Biopharm200152210311211522474
- KhandavilliSPanchagnulaRNanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in ratsJ Invest Dermatol2007127115416216858422
- BarcelóRViteriAMuñozAGil-NegreteARubioILopez-VivancoGPaclitaxel for progressive basal cell carcinomaJ Am Acad Dermatol2006542 SupplS50S5216427996
- PaolinoDCeliaCTrapassoECilurzoFFrestaMPaclitaxel-loaded ethosomes(R): potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratosesEur J Pharm Biopharm201281110211222414731
- KunstfeldRWickenhauserGMichaelisUPaclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a “humanized” SCID mouse modelJ Invest Dermatol2003120347648212603862
- HosmerJMShinSHNornooAZhengHLopesLBInfluence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxelJ Pharm Sci201110041444145520957759
- HosmerJMSteinerAALopesLBLamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceridePharm Res201330369470623135821
- UtrejaPJainSTiwaryAKLocalized delivery of paclitaxel using elastic liposomes: Formulation development and evaluationDrug Deliv201118536737621428706
- KilfoyleBESheihetLZhangZLaohooMKohnJMichniak-KohnBBDevelopment of paclitaxel-TyroSpheres for topical skin treatmentJ Control Release20121631182422732474
- LopesLBOvercoming the cutaneous barrier with microemulsionsPharmaceutics201461527724590260
- McClementsDJNanoemulsions versus microemulsions: terminology, differences, and similaritiesSoft Matter2012817191729
- PepeDMcCallMZhengHLopesLBProtein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agentJ Pharm Sci201310251476148723436680
- Cohen-AvrahamiMShamesAIOttavianiMFAserinAGartiNHIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophasesJ Phys Chem B2014118236277628724798650
- KimYCLateSBangaAKLudovicePJPrausnitzMRBiochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pHInt J Pharm20083621–2202818601987
- BaspinarYKeckCMBorchertHHDevelopment of a positively charged prednicarbate nanoemulsionInt J Pharm20103831–220120819747968
- ZieglerAThermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycansAdv Drug Deliv Rev2008604–558059718045730
- DeshayesSPlénatTAldrian-HerradaGDivitaGLe GrimellecCHeitzFPrimary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranesBiochemistry200443247698770615196012
- PoogaMHällbrinkMZorkoMLangelUCell penetration by transportanFASEB J199812167779438412
- MadaniFLindbergSLangelUFutakiSGräslundAMechanisms of cellular uptake of cell-penetrating peptidesJ Biophys2011201141472921687343
- Cohen-AvrahamiMLibsterDAserinAGartiNPenetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenacJ Control Release2012159341942822306174
- KrämerSDWunderli-AllenspachHNo entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptidesBiochim Biophys Acta20031609216116912543377
- WadiaJSStanRVDowdySFTransducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macro-pinocytosisNat Med200410331031514770178
- Schmid-WendtnerMHKortingHCThe pH of the skin surface and its impact on the barrier functionSkin Pharmacol Physiol200619629630216864974
- KimYCLudovicePJPrausnitzMROptimization of transdermal delivery using magainin pore-forming peptideJ Phys Chem Solids2008695–61560156320622979
- PatlollaRRDesaiPRBelayKSinghMSTranslocation of cell penetrating peptide engrafted nanoparticles across skin layersBiomaterials201031215598560720413152
- RachakondaVKYerramsettyKMMadihallySVRobinsonRLJrGasemKAScreening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skinPharm Res200825112697270418683029
- HerwadkarASachdevaVTaylorLFSilverHBangaAKLow frequency sonophoresis mediated transdermal and intradermal delivery of ketoprofenInt J Pharm2012423228929622172289
- ThomasSVieiraCSHassMALopesLBStability, cutaneous delivery, and antioxidant potential of a lipoic acid and alpha-tocopherol codrug incorporated in microemulsionsJ Pharm Sci201410382530253824961388
- MohammedDHirataKHadgraftJLaneMEInfluence of skin penetration enhancers on skin barrier function and skin protease activityEur J Pharm Sci20145111812224063883
- VoegeliDThe effect of washing and drying practices on skin barrier functionJ Wound Ostomy Continence Nurs2008351849018199943
- LehmannLKeipertSGloorMEffects of microemulsions on the stratum corneum and hydrocortisone penetrationEur J Pharm Biopharm200152212913611522477
- WelssTBasketterDASchröderKRIn vitro skin irritation: facts and future. State of the art review of mechanisms and modelsToxicol In Vitro200418323124315046769
- FojoTMenefeeMMechanisms of multidrug resistance: the potential role of microtubule-stabilizing agentsAnn Oncol200718Suppl 5v3v817656560
- DesaiAVyasTAmijiMCytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulationsJ Pharm Sci20089772745275617854074
- RubinAIChenEHRatnerDBasal-cell carcinomaN Engl J Med2005353212262226916306523
- KwasniakLAGarcia-ZuazagaJBasal cell carcinoma: evidence-based medicine and review of treatment modalitiesInt J Dermatol201150664565821595656
- BaspinarYBorchertHHPenetration and release studies of positively and negatively charged nanoemulsions-Is there a benefit of the positive charge?Int J Pharm20124301–224725222486953
- BernhoferLPBarkovicSAppaYMartinKMIL-1alpha and IL-1ra secretion from epidermal equivalents and the prediction of the irritation potential of mild soap and surfactant-based consumer productsToxicol In Vitro199913223123920654480
- HosmerJReedRBentleyMVNornooALopesLBMicroemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugsAAPS PharmSciTech200910258959619440842
- SugitaTYoshikawaTMukaiYComparative study on transduction and toxicity of protein transduction domainsBr J Pharmacol200815361143115218223668
- El-AndaloussiSJarverPJohanssonHJLangelUCargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative studyBiochem J2007407228529217627607
- WangYHChenCPChanMHArginine-rich intracellular delivery peptides noncovalently transport protein into living cellsBiochem Biophys Res Commun2006346375876716781666
- LopesLBBrophyCMFurnishEComparative study of the skin penetration of protein transduction domains and a conjugated peptidePharm Res200522575075715906170
- PourmousaMWong-ekkabutJPatraMKarttunenMMolecular dynamic studies of transportan interacting with a DPPC lipid bilayerJ Phys Chem B2013117123024123214935
- SaarKLindgrenMHansenMCell-penetrating peptides: a comparative membrane toxicity studyAnal Biochem20053451556516137634
- FuHShiKHuGTumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol)J Pharm Sci201510431160117325449709
- AkhlaghiSPSaremiSOstadSNDinarvandRAtyabiFDiscriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell linesNanomedicine201065919447208
- ChoritzLGrubJWegnerMPfeifferNThiemeHPaclitaxel inhibits growth, migration and collagen production of human Tenon’s fibroblasts – potential use in drug-eluting glaucoma drainage devicesGraefes Arch Clin Exp Ophthalmol2010248219720619898860
- SchmookFPMeingassnerJGBillichAComparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorptionInt J Pharm20012151–2515611250091
- ZghoulNFuchsRLehrCMSchaeferUFReconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulationsALTEX200118210310611378682
- SarkoDBeijerBGarcia BoyRThe pharmacokinetics of cell-penetrating peptidesMol Pharm2010762224223120845937
- JarverPMagerILangelUIn vivo biodistribution and efficacy of peptide mediated deliveryTrends Pharmacol Sci2010311152853520828841
- KimYCLudovicePJPrausnitzMRTransdermal delivery enhanced by magainin pore-forming peptideJ Control Release2007122337538317628164